Friday, Sep 20 2019 | Time 04:27 Hrs(IST)
image
  • German detective to disclose MH17 crash evidence only in presence of interested parties
  • Pentagon declines to comment on origin of Saudi oil attack
  • Russia gathers intelligence on Saudi oil strike - Naryshkin
  • At least 5 people killed, 20 injured in bus explosion in Yemen - Reports
  • Rain god in no mood to leave MP
  • Gas-like odour reported in Mumbai
  • Ousted Tunisian President Ben Ali dies in Saudi Arabia – Reports
  • Gas-like odour reported in Mumbai
  • MP Govt’s ambitious plan to acquaint young minds with the Mahatma
  • MP CM’s condolences
  • Indian High Commission Bangladesh hosts reception to celebrate ITEC Day
  • US hopes for peaceful resolution with Iran after attack on Saudi oil - Pompeo
  • CISF detects six gold bars worth Rs 1 90 cr, foreign currency worth Rs 20 lakh at IGI Airport
  • Congress will be wiped out in Punjab: Shwait Malik
  • Kaithal :Farmers burning crop residue to face tough action
Science Technology


WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

Kolkata, Aug 30 (UNI) The World Health Organization (WHO) has revised its guidance on

contraceptive use to reflect new evidence that women at high risk of HIV can use any form

of reversible contraception, including progestogen-only injectables, implants and intrauterine

devices (IUDs), without an increased risk of HIV infection.

However, as these contraceptive methods do not protect against HIV and other sexually

transmitted infections (STIs), the guideline emphasizes that correct and consistent use of

condoms should be used where there is a risk of STIs, including HIV, a WHO media

statement here on Friday said.

WHO also recommends considering offering pre-exposure prophylaxis (PrEP) in settings

where the incidence of HIV is above 3 per cent, as appropriate.

The updated WHO guideline follows a thorough review of the latest scientific evidence.

It emphasizes that women should have access to the full range of modern contraceptive

methods so they can make informed choices around contraceptive choice and their sexual

health.

“Evidence shows that a woman’s risk of HIV should not restrict her contraceptive choice,”

said Dr Peter Salama, Executive Director, Universal Health Coverage/Life Course at WHO.

“All women should have access to a wide range of options for contraception as well as to

HIV prevention and to treatment if needed.”

The updated recommendations to the WHO guideline, Medical eligibility criteria for

contraceptive use, stem from a review of the latest evidence conducted by the independent

Guideline Development Group convened to inform WHO.

This Group assessed all of the evidence on hormonal contraception and risk of HIV

acquisition published since the previous review published in 2016, along with a systematic

review of all published evidence on copper-bearing IUDs and HIV risk.

The new evidence is largely based on the results of the Evidence for Contraceptive

Options and HIV Outcomes (or ECHO trial) - a randomized clinical trial that showed no

statistically significant differences in HIV acquisition among women using intramuscular

depot medroxyprogesterone acetate (DMPA-IM), copper IUDs, or levonorgestrel (LNG)

implants.

This new high-quality evidence supersedes the low to low-moderate quality evidence

from observational studies that had been previously available to inform WHO’s guidance.

The ECHO study – which was conducted across communities expected to have high

levels of HIV prevalence in Eswatini, Kenya, South Africa and Zambia - also revealed

concerningly high levels of HIV acquisition and other sexually transmitted infections (STIs)

among women seeking contraceptive services, particularly younger women, irrespective

of which of the three contraceptive methods they used.

“There is a clear need to ensure women in Africa have access to high quality HIV and

STI prevention and testing services, along with a wide range of contraceptive options to

suit their values, preferences, views and concerns,” said Dr Felicitas Zawaira, Director of

Family and Reproductive Health in WHO’s African region.

“In high HIV prevalence settings, these may include condom promotion, pre-exposure

prophylaxis (PrEP), as well as linkages to antiretroviral therapy for those testing HIV-positive,

and partner testing.”

MORE UNI BM SJC

More News
WHO calls for urgent action to reduce patient harm in healthcare

WHO calls for urgent action to reduce patient harm in healthcare

14 Sep 2019 | 10:25 AM

Kolkata, Sep 14 (UNI) Millions of patients are harmed each year due to unsafe health care worldwide resulting in 2.6 million deaths annually in low-and middle-income countries alone.

see more..
WHO South-East Asia Region sets 2023 target to eliminate measles, rubella

WHO South-East Asia Region sets 2023 target to eliminate measles, rubella

05 Sep 2019 | 2:11 PM

New Delhi, Sep 5(UNI) Member countries of WHO South-East Asia Region on Thursday resolved to eliminate measles and rubella by 2023, to prevent deaths and disabilities caused by these highly infectious childhood killers diseases.

see more..
WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

30 Aug 2019 | 1:21 PM

Kolkata, Aug 30 (UNI) The World Health Organization (WHO) has revised its guidance on
contraceptive use to reflect new evidence that women at high risk of HIV can use any form
of reversible contraception, including progestogen-only injectables, implants and intrauterine
devices (IUDs), without an increased risk of HIV infection.

see more..
Taking the pulse of peatland carbon emissions could measure climate impact of development: Scientists

Taking the pulse of peatland carbon emissions could measure climate impact of development: Scientists

14 Aug 2019 | 4:58 PM

New Delhi, Aug 14 (UNI) A new way to 'take the pulse' of carbon emissions could help track how the industrial development of peatlands contributes to climate change, as well as measure their recovery once it ends, according to researchers.

see more..
Too much time on smartphones leads to obesity, deadly disease

Too much time on smartphones leads to obesity, deadly disease

27 Jul 2019 | 5:47 PM

New York, Jul 27 (UNI) Smartphone addiction could lead to serious weight gain and the onslaught of deadly diseases, according to a new study.

see more..
image